Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
miércoles, agosto 26
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
GoodRx Holdings Inc
GDRX
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$3.48
0.035
1.02%
al cierre: Aug 25, 5:00 PM EST
$3.48
0.005
0.14%
After hour: 7:46 PM EST
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
GoodRx Holdings Financials
GoodRx Holdings (GDRX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
GoodRx Holdings Raises FY2026 Sales Guidance from $765.000M-$785.000M to $790.000M-$805.000M vs $775.751M Est
GoodRx Holdings (NASDAQ:GDRX) raises FY2026 sales outlook from $765.000 million-$785.000 million to $790.000 million-$805.000 million vs $775.751 million estimate.
Benzinga Newsdesk
PRO
GoodRx Holdings Q2 Adj. EPS $0.08, Inline, Sales $200.411M Beat $193.162M Estimate
GoodRx Holdings (NASDAQ:GDRX) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. This is a 11.11 percent decrease over earnings of $0.09 per share from the same period last year.
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights
PRO
GoodRx Holdings Raises FY2026 Sales Guidance from $750.000M-$780.000M to $765.000M-$785.000M vs $764.443M Est
GoodRx Holdings (NASDAQ:GDRX) raises FY2026 sales outlook from $750.000 million-$780.000 million to $765.000 million-$785.000 million vs $764.443 million estimate.
Benzinga Newsdesk
PRO
GoodRx Holdings Q1 Adj. EPS $0.07, Inline, Sales $194.006M Beat $185.137M Estimate
GoodRx Holdings (NASDAQ:GDRX) reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. This is a 22.22 percent decrease over earnings of $0.09 per share from the same period last year.
Benzinga Newsdesk
PRO
GoodRx Holdings Sees FY2026 Sales $750.000M-$780.000M vs $815.142M Est
Benzinga Newsdesk
Privacy Manager